Net Revenues Net revenues were $4.9 million for the

New Post Public Reply Private Reply Replies (0) Message Board
jmoney360
265
Net Revenues



Net revenues were $4.9 million for the three months ended March 31, 2023, as compared to net revenues of $1.1 million for the three months ended March 31, 2022, an increase of $3.8 million. We attribute the increase in net revenues to increased billings related primarily to greater inpatient admissions and increased collections at our Big South Fork Medical Center. We began billing as a Critical Access Hospital in the three months ended June 30, 2022 retroactive to July 1, 2021.



Direct Cost of Revenues



Direct costs of revenues increased by $0.5 million for the three months ended March 31, 2023 compared to the three months ended March 31, 2022. We attribute the increase primarily to higher professional fees and salaries and wages. Professional fees increased due to greater inpatient admissions and to the restructuring of our relationships with certain professional service firms. Salaries and wages increased due to greater inpatient admissions, increased non-clinical staffing and reduced contract labor.



General and Administrative Expenses



General and administrative expenses increased by $0.6 million in the three months ended March 31, 2023 compared to the three months ended March 31, 2022. Our hospitals’ general and administrative expenses contributed approximately $0.4 million of the increase due primarily to increased salaries and wages and professional and purchased services. In addition, we incurred $0.1 million of additional corporate related expenses and $0.1 million of startup expenses associated with our newly-formed behavioral health subsidiary.
Income (loss) from Continuing Operations Before Other Income (Expense) and Income Taxes



Income from continuing operations before other income (expense) and income taxes for the three months ended March 31, 2023 was $0.8 million compared to a loss of $1.9 million for the three months ended March 31, 2022. We attribute the income in the three months ended March 31, 2023 compared to the loss in the three months ended March 31, 2022 to the $3.8 million increase in net revenues in the three months ended March 31, 2023 compared to the comparable 2022 period, partially offset by higher direct costs of net revenues and general and administrative expense in the three months ended March 31, 2023 versus the 2022 period.
1

Rennova Health, Inc. (RNVA) Stock Research Links

RNVA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Sales Focus Inc. Awarded as Leading Medical Outsourcing Service

Updated Category News Views 112

Sales Focus Inc.: Leading the Way in Healthcare Outsourcing Sales Focus Inc. (SFI) proudly announces its recognition as the Top Healthcare and Medical Sales Outsourcing Service for 2025. This prestigious accolade showcases the company's vital role in revolutionizing the healthcare sector with its innovative full-lifecycle sales execution model and robust industry...

Continue Reading
The Rise of Autonomous Data Platforms in the Tech Industry

Updated Category News Views 76

Exploring the Autonomous Data Platform Market Growth The world of data management is rapidly evolving, with the Autonomous Data Platform Market projected to reach an impressive USD 14.96 billion by 2032. This explosive growth expands at a significant CAGR of 27.89% from its current valuation, representing a fundamental shift in how organizations interact with their data....

Continue Reading
Enpro's Recent Insider Activity Signals Strong Future Potential

Updated Category News Views 177

Insider Purchase by William Abbey at Enpro In the latest SEC filing, the market received noteworthy news about Enpro. William Abbey, who serves as a Director at Enpro (NYSE:NPO), demonstrated significant confidence in the company by purchasing 567 shares for a total of $139,997. What This Purchase Indicates This insider transaction suggests a strong belief in Enpro's...

Continue Reading
Massive Increase in BNB Fund for Cancer Patients Unveiled

Updated Category News Views 168

BNB Donation Achieves Remarkable Growth Recently, an incredible story surfaced about the untouched donation made in BNB (CRYPTO: BNB) for cancer patients. This donation, originally valued at $200,000, has soared to an astonishing $39 million thanks to the surging market value of cryptocurrencies, particularly BNB. Impact of Cryptocurrency Fluctuation on Charity Funds...

Continue Reading
Bio X Cell Refreshes Brand Identity to Enhance Global Research Impact

Updated Category News Views 171

Bio X Cell Unveils a Fresh Brand Identity Bio X Cell, recognized as the global leader in functional antibodies tailored for in vivo and emerging preclinical models, has introduced a modernized brand identity. This change is a testament to nearly three decades of excellence in the field, seamlessly merging scientific innovation with expanding global capabilities in...

Continue Reading